ARCHIVES

CTEP Publishes Final Version of Plan for Assigning Intellectual Property Rights On Correlative Research

This article is from The Cancer Letter archive.

Vol. 37 No. 14 | April 8, 2011

Download PDF Visit The Full Archive

Related Articles

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980

Unique Molecular Profile For Lung Cancer Described

March 31, 2006

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

September 28, 2007

Largest Oncological Society Exerts Clout, Getting Results

June 24, 1983

FDA Pettiness Holds Up Trials with Promising Anticancer Drugs

November 14, 1975